Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone Depot vs Placebo in Schizophrenia
NCT00253136Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Nov 1999; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00253136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253136.